Director Dermot Mark Durcan bought 4,000 COR shares at $266.26; stock down 29.1% from 52-week high, prior COR buy returned +10.1% in 90 days.
Durcan's $1,065,040 purchase of 4,000 shares (16.8% increase to his 27.8K total holding) occurs as Cencora trades at $267.71, down 29.1% from its 52-week high of $377.54 and off 28.1% over the past 90 days. His prior open-market purchase of Cencora stock on 2024-05-24 generated a 90-day return of +10.1%, demonstrating a prior instance of well-timed buying at this ticker. Against a backdrop of revenue of $78.4B with 9.3% annual growth and a P/E of 20.44, the director is adding to his position during a period of significant price depreciation. The timing relative to the stock's recent downward trajectory and his demonstrated track record of successful buys at this company merits attention to whether this signals conviction in the company's recovery fundamentals.